The prevalence of DVT (deep vein thrombosis) and PE (pulmonary embolism) is a major public health crisis. Among hospitalized patients it affects approximately 2 million cases annually and is the leading cause of death in hospitalized patients. DVT/PE kills up to 200,000 people annually -- more than AIDS, breast cancer and highway fatalities combined.

Because DVT/PE occurs in many areas of the hospital, there has been a lack of ownership of this problem. Prevention must become a prominent part of the hospital's quality improvement and safety strategies. As the Sixth ACCP Consensus Conference on Antithrombotic Therapy recently stated: "The rationale for thromboprophylaxis is based on the high prevalence of veinous thromboembolism among hospitalized patients, the clinically silent nature of the disease in the majority of patients, and the morbidity, costs and potential mortality associated with unprevented thrombi."

This program will look at the prevalence and risk factors for venous thromboembolism and show effective strategies to reduce the incidence of DVT and PE among hospitalized patients.

PROGRAM REQUIREMENTS FOR ALL DESCIPLINES
Participants have to complete a Continuing Education Registration form and log their attendance on the sign in sheet (for each session if applicable). VHA will mail a continuing education certificate to participants who successfully complete the program requirements 45 to 60 days after the educational activity.

VHA is committed to complying with the strict criteria set forth by the accreditation and continuing education approval agencies in order to provide this quality program. To receive credit for educational activities you must successfully complete all program requirements.

This program is supported by an educational grant from Aventis Pharmaceuticals and provided free of charge via satellite..